Skip to main content

Health Wildcatters


Last Tuesday I attended a kickoff meet-and-greet for Health Wildcatters, a new Dallas-based healthcare-oriented seed accelerator. My impression of the event? Electrifying. The venue ("Tech Church," headquarters for both Health Wildcatters and its older sibling Tech Wildcatters) was filled to the brim with people collectively representing an incredibly diverse array of business and technical expertise. For an illustration of the diversity of talent present within Health Wildcatters' orbit, take a look at the profiles of the mentors (58 in all) who have signed up to serve as coaches for its incoming startups. I had the fortune of having conversations with a number of them at the event. One was with Charley Kiser, President & CEO of management consultancy C. H. Kiser & Company, LLC, who told me that the difficulties that exist in sharing patient information between hospitals is driven only partially by technical constraints (e.g., lack of compatibility between different EHR systems, etc.) and that the lack of business incentives for hospitals to streamline data sharing may in fact be a bigger driver. Another was with David Sym-Smith, Partner at Mobility Ventures, who expressed incredible enthusiasm about the potential of mobile technologies to upend current models of healthcare delivery, up to and including the dissolution of hospitals as they currently exist. Taken in the aggregate, the level of talent and experience represented by the mentors on board at Health Wildcatters is amazing and bodes well for its success.

Go to http://healthwildcatters.com/news/ to see all of the media coverage Health Wildcatters has received. Photos from the meet-and-greet event can be found here and here.  


- Isamu Z. Hartman, PhD

Comments

Post a Comment

Popular posts from this blog

Comics About Patents (A Work In Progress)

Back in January and February of 2018, I spent some time creating two four-panel comics about the process of 1) obtaining patent protection, and 2) monetizing those patent rights by licensing them. I drew the comics to serve as an illustration of concepts that I often find myself explaining to others in the course of my work. I've already shared these comics through  Twitter  and  Facebook  (click on either of link to see more of the creative process!). However, I thought I'd share them with my blog's readership as well. Please enjoy! I'm really hoping to reignite this project at some point in the future and create more episodes. (Click on the images below to enlarge) Episode 1: Episode 2: - Isamu Hartman
Post a Comment
Read more

The Big Fish: Texas-Based Biomedical Companies listed on NYSE and NASDAQ

[Monday, 22 April 2013:  I added Hanger Inc. (HGR, NYSE), an Austin-based prosthetics and orthotics company I had originally missed, to the list] [Thursday, 02 May 2013:  fixed the location of Hanger Inc. (HGR, NYSE) - changed from Dallas to Austin] I have another few posts coming up on Texas-based awardees of the SBIR program. But first, a quick digression. +Levi Shapiro  asked me the following question during a phone conversation we had earlier today:  who are the "Big Players" in the Texas biomedical industry that are listed in the major stock exchanges? I knew about Luminex (LMNX, NASDAQ) off the top of my head. Other than that, though, I really had no idea. Following the advice of +Lauren Nise  , I used LexisNexis (courtesy of the UT Dallas Eugene McDermott Library ) to generate a list of publicly traded biomedical companies headquartered in Texas that are listed in either NYSE or NASDAQ. Here are the companies I found: (Open spreadsheet as a se...
Post a Comment
Read more

Corporate Venture Capital at the Top 10 Pharma/Biotech Companies

Today I'm taking a step outside of Texas and looking at the world. Many large pharmaceutical and biotech firms maintain venture capital operations through which they invest in early-stage biomedical companies. I wanted to get a sense of what these biopharma corporate venture capital (CVC) funds are up to. Which companies have CVC funds? How active are they? What are their goals? What are they investing in? Background: general and sector-specific trends in venture capital In 2014 venture capital funding in the U.S. hit its highest annual mark since 2001, as investors participated in $47.3 billion across 3,617 deals . Within this trend Life Sciences was the second largest sector (behind only the Media and Entertainment sector) for 2014 in dollar terms with $8.6 billion invested in 789 deals, the highest level since 2007 . Corporate venture funding has followed similar trends:  2014 marked the strongest year for CVC activity since 2000 with $5.4 billion invested in U.S.-based co...
Post a Comment
Read more